Indemnification AgreementIndemnification Agreement • March 5th, 2018 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is made and entered into as of [DATE] (the “Effective Date”) by and between Emerald Health Pharmaceuticals Inc., a Delaware corporation (the “Company”), and [INDEMNITEE NAME] (the “Indemnitee”).
SUBSCRIPTION AGREEMENTSubscription Agreement • March 5th, 2018 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
THIS SUBSCRIPTION AGREEMENT (this “Agreement” or this “Subscription”) is made and entered into as of ______________, by and between the undersigned (the “Subscriber”) and Emerald Health Pharmaceuticals Inc., a Delaware corporation (“Emerald Pharmaceuticals”), with reference to the facts set forth below.
LOAN AGREEMENTLoan Agreement • March 5th, 2018 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations
EMERALD HEALTH SCIENCES INC., a corporation incorporated under the laws of British Columbia with an office at 200-375 Water St. Vancouver, BC, V6B 0M9
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • March 5th, 2018 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
VCE-004: All new uses of cannabinoid derivatives of the Series 4 that would be technical subject matter that is not excluded from patentability based on the chemical backbone described below, and including the embodiments described below.
CONSULTING AGREEMENT Córdoba, <@> May 2017 MEETING OF THE PARTIESConsulting Agreement • March 5th, 2018 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
OF A PART: D. Eduardo Muñoz Blanco of legal age, with ID 30448749S, and with N.R.P. 3044874924A0500, Professor of Immunology, belonging to the Department of Cellular Biology, Physiology and Immunology of the University of Cordoba, acting on behalf of the latter by virtue of the authorization granted to sign this contract dated XX-05-2017 in accordance with the provisions of Article 83 of Organic Law 6/2001 of Universities, of December 21, and in articles 142 to 144 of the statutes of the University of Córdoba
AMENDMENT AGREEMENTAmendment Agreement • March 5th, 2018 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations
EMERALD HEALTH SCIENCES INC., a corporation incorporated under the laws of British Columbia with an office at 200-375 Water St. Vancouver, BC, V6B 0M9
Intellectual Property Transfer AgreementIntellectual Property Transfer Agreement • March 5th, 2018 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
VCE-004: All new uses of cannabinoid derivatives of the VCE-004 series that would be technical subject matter that is not excluded from patentability based on the chemical backbone described below, and including the embodiments described below.
